AgingResearch.NewsJoin free

S-2P + aluminum hydroxide

S-2P + aluminum hydroxide has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 3, 2025: “Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on S-2P + aluminum hydroxide

At a glance

The findings reach mice, none yet in people. 1 lab in 2 countries.

Mice: a single group. Cells, worms or flies and humans: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 2 countries
  • Funders: Ministry of Science and Technology of the People's Republic of China and 1 more
  • Animals1

What did studies of S-2P + aluminum hydroxide find?

1

Studies of S-2P + aluminum hydroxide measured 1 outcome; the most studied are antibody titers (1 study).

Antibody titers

upin mice1

1 study

  1. S-2P + aluminum hydroxide increases antibody titers in mice.

    “a third dose of S-2P:Al following a prime-boost regimen triggered a robust increase in antibody levels”

    AnimalsThird dose following a prime-boost regimen

    Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations

    Journal of virology

More on Antibody titers

Latest

Related